Narrative review / 2019
Short-term fasting is safe but challenging in cancer patients receiving chemotherapy, while efficacy trials remain in their infancy.
This review summarizes preclinical and clinical evidence on the molecular mechanisms and effects of short-term fasting (STF) alongside cancer chemotherapy. Preclinical data show STF enhances the efficacy of various chemotherapeutic agents and protects healthy cells from toxicity. In humans, preliminary findings suggest STF is safe but challenging for cancer patients receiving chemotherapy, with clinical research still in its infancy.
- Study type
- Review
- Who was studied
- Cancer patients receiving chemotherapy
- What was measured
- Safety, tolerability, toxicity, and efficacy of chemotherapy with short-term fasting
THE PAPER
Effects of short-term fasting on cancer treatment.
de Groot S, Pijl H, van der Hoeven JJM, Kroep JR. J Exp Clin Cancer Res, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.